| Ytd | -94.59% | |
| 1y | -86.58% |
| Open | 0.17 | Prev Close | 0.16 | Low | 0.16 | High | 0.17 | Mkt Cap | 81.98M |
| Vol | 11.30M | Avg Vol | 11.93M | EPS | -0.79 | P/E | N/A | Forward P/E | -1.24 |
| Beta | 1.96 | Short Ratio | 6.29 | Inst. Own | 77.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 0.25 | 200-d Avg | 1.66 | 1yr Est | 7.61 |
GOSS News
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B
Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company" or "Gossamer"), a biopharmaceutical
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a
Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company"), a biopharmaceutical company focused on the
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.20) per share which missed the analyst c
Top Wall Street analysts changed outlook on top names, downgrading ZBH, GOSS, TRI, PCG, and BOX. See
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst c
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B
Oppenheimer analyst Andreas Argyrides maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and
Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term p
Wedbush analyst Laura Chico downgrades Gossamer Bio (NASDAQ:GOSS) from Outperform to Neutral and
Barclays analyst Eliana Merle downgrades Gossamer Bio (NASDAQ:GOSS) from Overweight to Underweigh
Leerink Partners analyst Joseph Schwartz downgrades Gossamer Bio (NASDAQ:GOSS) from Outperform to
Gossamer Bio shares plunge after Phase 3 pulmonary arterial hypertension data miss key mark, despite
- Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.
Barclays analyst Eliana Merle initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Overweight
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the comp
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
Friday's session saw 169 companies set new 52-week lows.
Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched larg
On Tuesday, 91 stocks hit new 52-week lows.
Thursday's session saw 337 companies set new 52-week lows.
On Friday, 497 companies set new 52-week lows.
OnFriday, 143 stocks hit new 52-week lows.
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co